Sources of variability in estimates of the prevalence of Alzheimer's disease in the United States.
about
Monetary costs of dementia in the United StatesConvergent genetic and expression data implicate immunity in Alzheimer's diseaseA classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortium.Gender and incidence of dementia in the Framingham Heart Study from mid-adult lifeUsing U.S. Medicare records to evaluate the indirect health effects on spouses: a case study in Alzheimer's disease patients.Prevalence of cognitive impairment in individuals aged over 65 in an urban area: DERIVA study.Physical activity for people with dementia: a scoping study.Epigenomics of Alzheimer's disease.Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 2.Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies.Dementia and Alzheimer's disease: a new direction.The 2010 Jay L. Foster Memorial Lecture.Future Monetary Costs of Dementia in the United States under Alternative Dementia Prevalence Scenarios.Overview and findings from the rush Memory and Aging ProjectAre clinical diagnoses of Alzheimer's disease and other dementias affected by education and self-reported race?Hospital and nursing home use from 2002 to 2008 among U.S. older adults with cognitive impairment, not dementia in 2002The Value of Delaying Alzheimer's Disease Onset.Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.Oxidative stress and β-amyloid protein in Alzheimer's disease.Opioid system and Alzheimer's disease.Is Vasomotion in Cerebral Arteries Impaired in Alzheimer's Disease?Exposure to air pollution as a potential contributor to cognitive function, cognitive decline, brain imaging, and dementia: A systematic review of epidemiologic researchThe Prevalence and Incidence of Dementia Due to Alzheimer's Disease: a Systematic Review and Meta-Analysis.Obstetrician/gynecologist care considerations: practice changes in disease management with an aging patient population.Treatment Patterns with Antidementia Drugs in the United States: Medicare Cohort Study.Secondary Analysis of Existing Datasets for Dementia and Palliative Care Research: High-Value Applications and Key Considerations.Prevalence of Cognitive Impairment and Association With Survival Among Older Patients With Hematologic Cancers.The Impact of Changes in Population Health and Mortality on Future Prevalence of Alzheimer's Disease and Other Dementias in the United States.Short-Term Changes in the Prevalence of Probable Dementia: An Analysis of the 2011-2015 National Health and Aging Trends Study.Dementia in the USA: state variation in prevalence.Population-Based Analysis of Incidence Rates of Cancer and Noncancer Chronic Diseases in the US Elderly Using NLTCS/Medicare-Linked Database
P2860
Q28288245-703A1510-8518-455F-A8E7-3255FD7310DCQ30881547-A68B7725-FE2B-4A29-BD78-BE3E78C84E98Q33813921-81B626DF-B4B0-4B79-B2CD-BF3B65CA8A3DQ33882491-A03E34E0-B165-480C-8714-2A358D4487FEQ33926841-700E67B2-D4FB-4517-89BE-EE3516D5503EQ34076874-8CBE05FF-4936-4559-8CE1-8C1B544572D7Q34464069-F273ED8C-C038-4AC3-A4CB-AE435C274A1BQ34518584-85A798D6-A986-4C5C-B6C7-C85E14E44049Q34577636-C0DDBC36-75D1-4CA0-BBF7-32E099A01816Q35231770-C7F2F27D-97C0-4503-BDFD-C1C2A67B8FBDQ35394390-1A02E347-908F-4D13-B2EC-3597657EDCAEQ35541878-65EDC47B-17FC-49D2-B7EB-245EDB2D4E60Q36226167-266F0CFA-F19F-44C5-96A0-1072F7A57F2BQ36455435-6A0902DE-D869-413E-B149-7087BA1D5793Q36714612-FF6A50E7-DE7F-4F6D-A1F5-2D4BB6B6AB08Q36852189-FC61ED12-1FFC-4B21-96CB-4B007D0366A7Q37035610-18AA2904-3BCD-43C6-93CF-6C9EDE9B6A6FQ37928994-021D6ED7-6CC6-439F-AD73-C6C5C1701A23Q38004941-E4AD8888-4D48-4EFD-8EFE-80C8EFBE6ECCQ38365567-7D050B57-9D61-4D18-A4F6-452A6DECFD48Q38850135-AD2F93C8-534B-41BB-A07F-029199B5D7AFQ38852543-0E1C0314-16A2-44C5-B7F2-B5686D7C5383Q39237422-4C403A98-B2D9-4170-A76E-35935D7E2AF0Q39657233-2A230910-A886-491C-90EC-033DC9169432Q47672288-77659EB8-7411-41F3-A990-7A5908AED0A4Q50533385-4A9683A3-410E-4077-BCD4-31327688811EQ52580255-36DB44F9-013F-44B4-A2B4-AF8B9B65A400Q52580256-4F0DEF4F-5302-4B7F-AA33-239FEFFC6AA1Q53357923-B9F5A72E-F0F3-4F7E-BBA3-DAC4D86F0726Q59001315-C799CCE2-9D5A-4C5E-ABF0-490B0831DE0D
P2860
Sources of variability in estimates of the prevalence of Alzheimer's disease in the United States.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Sources of variability in esti ...... disease in the United States.
@ast
Sources of variability in esti ...... disease in the United States.
@en
type
label
Sources of variability in esti ...... disease in the United States.
@ast
Sources of variability in esti ...... disease in the United States.
@en
prefLabel
Sources of variability in esti ...... disease in the United States.
@ast
Sources of variability in esti ...... disease in the United States.
@en
P2093
P2860
P1476
Sources of variability in esti ...... disease in the United States.
@en
P2093
Brenda L Plassman
Brent J Small
David R Weir
Denis A Evans
Kenneth M Langa
Liesi E Hebert
Robert S Wilson
P2860
P356
10.1016/J.JALZ.2010.11.006
P577
2011-01-01T00:00:00Z